Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses

被引:0
|
作者
Bingfeng Zuo
Yang Zhang
Kangjie Zhao
Li Wu
Han Qi
Rong Yang
Xianjun Gao
Mengyuan Geng
Yingjie Wu
Renwei Jing
Qibing Zhou
Yiqi Seow
HaiFang Yin
机构
[1] Tianjin Medical University,The Province and Ministry Co
[2] Huazhong University of Science and Technology,Sponsored Collaborative Innovation Center for Medical Epigenetics and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education) and School of Medical Technology and School of Basic Medical S
[3] Institute of Bioengineering and Bioimaging,Department of Nanomedicine and Biopharmaceuticals, National Engineering Research Center for Nanomedicine
[4] Institute of Molecular and Cell Biology,undefined
来源
Journal of Hematology & Oncology | / 15卷
关键词
Exosome; Hepatocellular carcinoma; Personalized immunotherapy; Adaptive and innate immunity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] A universal strategy designed for selecting bench-to-bedside aptamers to serum and validated in hepatocellular carcinoma diagnosis
    Wang, Ting
    Chen, Wen-Xue
    Chen, Zhi-Yong
    Xu, Guo-Feng
    Zhang, Bei
    Wei, Shu-Qin
    Hu, Jia
    Zhang, Kun-He
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 217 - 217
  • [32] Vaccinia virus expressing IL-37 promotes antitumor immune responses in hepatocellular carcinoma
    Zhang, Zhihao
    Zhang, Jingwen
    Zhang, Yingying
    Xing, Jiyuan
    Yu, Zujiang
    CELL BIOCHEMISTRY AND FUNCTION, 2019, 37 (08) : 618 - 624
  • [33] Tumor cyclooxygenase-2 gene suppresses local immune responses in patients with hepatocellular carcinoma
    Iwamoto, Akemi
    Ikeguchi, Masahide
    Matsumoto, Sachico
    Hukumoto, Youji
    Inoue, Masashi
    Ozaki, Tomohiro
    Ataka, Masayuki
    Tanida, Takashi
    Endo, Kanenori
    Katano, Kuniyuki
    Hirooka, Yasuaki
    TUMORI JOURNAL, 2006, 92 (02): : 130 - 133
  • [34] Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response
    Liu, Long
    Huang, Yanping
    Fu, Yanan
    Rao, Jingjing
    Zeng, Feng
    Ji, Manshan
    Xu, Xiang
    Zhu, Jianyong
    Du, Weixing
    Liu, Zhixin
    INFECTIOUS AGENTS AND CANCER, 2022, 17 (01)
  • [35] Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response
    Long Liu
    Yanping Huang
    Yanan Fu
    Jingjing Rao
    Feng Zeng
    Manshan Ji
    Xiang Xu
    Jianyong Zhu
    Weixing Du
    Zhixin Liu
    Infectious Agents and Cancer, 17
  • [36] Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
    Brown, Zachary J.
    Yu, Su Jong
    Heinrich, Bernd
    Ma, Chi
    Fu, Qiong
    Sandhu, Milan
    Agdashian, David
    Zhang, Qianfei
    Korangy, Firouzeh
    Greten, Tim F.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (08) : 1305 - 1315
  • [37] Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
    Zachary J. Brown
    Su Jong Yu
    Bernd Heinrich
    Chi Ma
    Qiong Fu
    Milan Sandhu
    David Agdashian
    Qianfei Zhang
    Firouzeh Korangy
    Tim F. Greten
    Cancer Immunology, Immunotherapy, 2018, 67 : 1305 - 1315
  • [38] Immune-related adverse events predict responses to PD-1 blockade immunotherapy in hepatocellular carcinoma
    Lu, Lianghe
    Xing, Kaili
    Wei, Wei
    Ling, Yihong
    Li, Peng
    Li, Shaohua
    Wang, Yan
    Xie, Dan
    Guo, Rongping
    Cai, Muyan
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (04) : 959 - 966
  • [39] Effect of gut microbiota intervention on inflammatory responses and cellular immune function in hepatocellular carcinoma patients undergoing radiotherapy
    Liu, Liying
    Fan, Yanna
    Pi, Hongying
    JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES, 2024, 17 (04)
  • [40] Learning the Roles of the Hepatic Adaptive Immune System in Hepatocellular Carcinoma-Nature's Guide for Successful Cancer Immunotherapy
    Heikenwaelder, Mathias
    Pikarsky, Eli
    SEMINARS IN LIVER DISEASE, 2017, 37 (03) : 210 - 218